NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Divi s Laboratories Limited (NSE: DIVISLAB)
DIVISLAB Technical Analysis
4
As on 27th Mar 2024 DIVISLAB SHARE Price closed @ 3367.85 and we RECOMMEND Sell for LONG-TERM with Stoploss of 3603.39 & Strong Sell for SHORT-TERM with Stoploss of 3642.77 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DIVISLABSHARE Price
Open | 3390.00 | Change | Price | % |
High | 3403.40 | 1 Day | -23.15 | -0.68 |
Low | 3350.00 | 1 Week | -60.45 | -1.76 |
Close | 3367.85 | 1 Month | -171.95 | -4.86 |
Volume | 506472 | 1 Year | 538.65 | 19.04 |
52 Week High 4564.60 | 52 Week Low 2750.85 |
DIVISLAB CURRENT MONTH FUTURE | |||
Close | 3369.95 | ||
Contracts Traded | 1574600 | ||
Open Intrest | 1160000 | ||
Change In O.I | -45.68 % | ||
Lot Size | 200 |
DIVISLAB CURRENT MONTH OPTION | |
Most Active Call | 3400.00 |
Most Active put | 3400.00 |
Highest O.I Buildup Call | 3600.00 |
Highest O.I Buildup Put | 3500.00 |
Expiry Date | 2024-03-28 |
DIVISLAB ALL MONTHS OPTIONS | |||
For All DIVISLAB Options Click Here |
NSE INDIA Most Active Stocks
IDEA | 13.30 | 0.00% |
YESBANK | 23.15 | -1.70% |
NHPC | 88.85 | 3.68% |
SUZLON | 38.50 | 3.77% |
IRFC | 142.85 | -1.96% |
RAMASTEEL | 14.15 | 9.27% |
ZEEL | 141.35 | 1.51% |
INFIBEAM | 34.80 | 0.14% |
IDFCFIRSTB | 77.80 | 0.13% |
DISHTV | 16.80 | -2.04% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
DIVISLAB Daily Charts |
DIVISLAB Intraday Charts |
Whats New @ Bazaartrend |
DIVISLAB Free Analysis |
|
DIVISLAB Important Levels Intraday
RESISTANCE | 3470.75 |
RESISTANCE | 3437.75 |
RESISTANCE | 3417.35 |
RESISTANCE | 3396.95 |
SUPPORT | 3338.75 |
SUPPORT | 3318.35 |
SUPPORT | 3297.95 |
SUPPORT | 3264.95 |
DIVISLAB Target March 2024
4th UP Target | 4684.61 |
3rd UP Target | 4354.54 |
2nd UP Target | 4150.51 |
1st UP Target | 3946.48 |
1st DOWN Target | 3364.32 |
2nd DOWN Target | 3160.29 |
3rd DOWN Target | 2956.26 |
4th DOWN Target | 2626.19 |
DIVISLAB Weekly Target
4th UP Target | 3677.24 |
3rd UP Target | 3598.41 |
2nd UP Target | 3549.69 |
1st UP Target | 3500.96 |
1st DOWN Target | 3361.94 |
2nd DOWN Target | 3313.21 |
3rd DOWN Target | 3264.49 |
4th DOWN Target | 3185.66 |
DIVISLAB Target2024
4th UP Target | 6258.69 |
3rd UP Target | 5503.5 |
2nd UP Target | 5036.69 |
1st UP Target | 4569.89 |
1st DOWN Target | 3237.91 |
2nd DOWN Target | 2771.11 |
3rd DOWN Target | 2304.3 |
4th DOWN Target | 1549.11 |
Divi s Laboratories Limited ( NSE INDIA Symbol : DIVISLAB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DIVISLAB Synopsis Technicals View
50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is Below 30 | Over Sold | |
MFI (14) | MFI is 46.25 | Sideways | |
CCI (20) | CCI is Below -100 | Over Sold | |
WILLIAM %R (14) | William %R is -71.68 | Sideways | |
ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
PSAR | Stoploss For Long Buy | 2178.35 | |
10 Day Avg Volume | Traded 10.69 % More then 10 Day Average Volume |
DIVISLAB Other Details
Segment | EQ | |
Market Capital | 1371665072128.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
DIVISLAB Address
DIVISLAB Latest News
DIVISLAB Business Profile
Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs), intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is headquartered in Hyderabad, India. Address: Divi Towers, Hyderabad, India, 500032
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service